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SUMMARY
Complex I (NADH:ubiquinone oxidoreductase) is
central to energy metabolism in mammalian mito-
chondria. It couples NADH oxidation by ubiquinone
to proton transport across the energy-conserving in-
ner membrane, catalyzing respiration and driving
ATP synthesis. In the absence of substrates, active
complex I gradually enters a pronounced resting or
deactive state. The active-deactive transition occurs
during ischemia and is crucial for controlling how
respiration recovers upon reperfusion. Here, we set
a highly active preparation of Bos taurus complex I
into the biochemically defined deactive state, and
used single-particle electron cryomicroscopy to
determine its structure to 4.1 A˚ resolution. We show
that the deactive state arises when critical structural
elements that form the ubiquinone-binding site
become disordered, and we propose reactivation
is induced when substrate binding to the NADH-
reduced enzyme templates their reordering. Our
structure both rationalizes biochemical data on the
deactive state and offers new insights into its physi-
ological and cellular roles.
INTRODUCTION
Complex I (NADH:ubiquinone oxidoreductase), a crucial enzyme
in oxidative phosphorylation, uses NADH oxidation and ubiqui-
none reduction to build the proton motive force across the inner
mitochondrial membrane, catalyzing respiration and driving ATP
synthesis (Hirst, 2013; Sazanov, 2015). Mammalian complex I,
one of the largest membrane-bound enzymes in the cell, con-
tains 45 subunits with a combined mass of 1 MDa; the 14 fully
conserved core subunits are required for catalysis, while the
31 supernumerary subunits may be required for enzyme assem-
bly, stability, or regulation (Fiedorczuk et al., 2016; Hirst et al.,
2003; Stroud et al., 2016; Vinothkumar et al., 2014; Walker,
1992; Zhu et al., 2016). The ‘‘active-deactive’’ transition of
mammalian complex I has recently come to prominence as a
physiologically relevant mechanism of regulation. In the absence
of substrates, complex I relaxes into a profound resting state,
known as the deactive state, that can be reactivated by addition
of NADH and ubiquinone (Babot et al., 2014a; Galkin and Mon-
cada, 2017; Kotlyar and Vinogradov, 1990; Vinogradov, 1998).
Notably, because the respiratory chain cannot catalyze in the
absence of O2 (lack of an electron acceptor prevents electron
flux along the chain), ischemia promotes complex I deactivation
(Galkin et al., 2009; Maklashina et al., 2002, 2004). Forming the
deactive state may be protective because, upon reintroduction
of O2 to the ischemic tissue, it is unable to catalyze the reverse
electron transport reaction that causes a damaging burst of
reactive oxygen species production (Chouchani et al., 2014).
Controlling complex I reactivation thus provides a rational strat-
egy for combating ischemia-reperfusion injury (Burwell et al.,
2009; Chouchani et al., 2013). Conversely, forming the deactive
state may also tend to increase ischemia-reperfusion injury
because it is more susceptible to oxidative damage than the
active state (Gorenkova et al., 2013), and strategies to target
and protect the deactive state may also prove effective.
Rapid progress has been made recently in the structure of
mammalian complex I due to a proliferation of structures for
the Bos taurus (bovine) (Vinothkumar et al., 2014; Zhu et al.,
2015, 2016), Sus scrofa (porcine) (Gu et al., 2016; Wu et al.,
2016), and Ovis aries (ovine) (Fiedorczuk et al., 2016; Letts
et al., 2016a) enzymes, both in their isolated forms and in super-
complex assemblies. All 45 subunits of the mammalian complex
have been assigned (Vinothkumar et al., 2014; Zhu et al., 2015,
2016) and modeled (Fiedorczuk et al., 2016; Wu et al., 2016;
Zhu et al., 2016), and in data from the bovine complex three
different structural classes were identified (Zhu et al., 2016).
The three classes were tentatively assigned to different func-
tional states of the complex. In the state referred to as class 1,
several regions around the ubiquinone-binding site were disor-
dered,whereas clear densities for themwere observed in class 2.
One of these regions is the loop between the first and second
transmembrane helices (TMHs) of subunit ND3, which contains
the reactive cysteine residue (Cys39) used as a biochemical
marker for the deactive state (Galkin et al., 2008). Cys39 can
only bemodified with thiol-reactive reagents such asN-ethylma-
leimide (NEM) in the deactive state (Galkin et al., 2008; Gavrikova
and Vinogradov, 1999). Because the cysteine is occluded in
class 2, but likely more accessible on its unstructured loop in
class 1, class 1 was tentatively assigned to the deactive state,
and class 2 to the active state (Zhu et al., 2016). A less populated
class that is most similar to class 1, class 3, was also observed
and refined to lower resolution. Its density map contains
312 Structure 26, 312–319, February 6, 2018 ª 2018 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
additional regions of disorder, including part of the transverse
helix that runs along the membrane domain appearing to strap
it together, and so class 3 was ascribed to enzyme molecules
in the process of dissociation (Zhu et al., 2016).
These tentative assignments of the active and deactive struc-
tures suggest that the deactive state results when structural
elements around the ubiquinone-binding site, including loops
in the ND1, ND3, and 49 kDa subunits, become disordered
(Zhu et al., 2016). It has been proposed that the localized disor-
der disrupts the substrate-binding site (rendering it catalytically
inactive), but that ubiquinone interacting with the site, when the
enzyme is reduced, serves as a template to restructure it (the de-
active state slowly reactivates when NADH and ubiquinone are
provided) (Dro¨se et al., 2016; Zhu et al., 2016). We refer to this
model as the ‘‘unfolded Q-site’’ model. Alternatively, other re-
searchers have proposed the ‘‘truncated Q-site’’ model. In the
crystal structure of complex I from Yarrowia lipolytica (Zicker-
mann et al., 2015), considered to be in the deactive state, the
top of the ubiquinone-binding cavity is occluded by the b1-b2
loop of the 49 kDa subunit, preventing the ubiquinone head
group reaching its binding site. The b1-b2 loop was subse-
quently modeled in a similar configuration in the structure of
ovine complex I (Fiedorczuk et al., 2016), and this structure
also ascribed to the deactive enzyme.
Here, to define the structure of the deactive state, we prepared
biochemically defined samples of deactive bovine complex I and
determined their structure by single-particle cryoelectron micro-
scopy (cryo-EM). Our preparations exhibit the well-known
biochemical characteristics of the deactive state of the mamma-
lian enzyme (Babot et al., 2014a; Galkin et al., 2008; Kotlyar and
Vinogradov, 1990; Vinogradov, 1998) and are highly catalytically
active following reactivation. The structure of the deactive
complex matches the previously described class 1 structure
(Zhu et al., 2016) and supports the unfolded Q-site model for
the deactive transition. Thus, our model provides a structural
foundation for interpreting the wealth of mechanistic, biochem-
ical, and physiological data on the deactive transition in
mammalian complex I and for understanding the role of deactive
complex I in ischemia-reperfusion injury.
RESULTS
Preparation of Highly Active Complex I in the
Deactive State
First, we developed a protocol to purify highly active bovine
complex I set fully in the deactive state. Our method was devel-
oped from the complex I preparation of Jones et al. (2016) but
with the final gel filtration step performed in the detergent
cymal-7, rather than in n-dodecyl b-D-maltoside (DDM), as it
was observed previously that cymal-7 gave a higher density
of particles on cryo-EM grids (Vinothkumar et al., 2014). To
convert the complex to the deactive state, the suspension of
mitochondrial membranes from which the preparation begins
was incubated at 37C for 15 min, before the detergent was
added for solubilization. The temperature and length of incuba-
tion were optimized by using NEM to determine the proportion
of the complex that is in the deactive state (Galkin et al., 2008).
NEM is able to react with Cys39 in the ND3 subunit in the de-
active enzyme but not in the active enzyme, and once Cys39
has been derivatized by NEM the complex is unable to reacti-
vate. Therefore, the activities observed in the presence and
absence of NEM can be used to quantify the deactive and
active states. Figure 1 shows that, in the presence of NEM,
the purified deactive enzyme prepared here displayed a very
slow, constant rate of catalysis, whereas in its absence a pro-
nounced lag phase was observed as the enzyme slowly reacti-
vated. Furthermore, the maximal rate of catalysis was
20 times higher in the absence of NEM (when it is due to
both the active and deactive states) than in its presence
(when it is due to only the active state), indicating that the
complex was 95% in the deactive state. Finally, by paying
particular attention to the time taken for each stage of the
preparation, the specific activity of the enzyme imaged here
(following reactivation) was improved from the value described
previously: from 14 ± 3 mmol NADH min1 mg1 (Jones
et al., 2016) to 22.2 to 24.7 mmol NADH min1 mg1
(390 NADH s1). The activities of equivalent preparations car-
ried out without the deactivation step were comparable. These
activities match those of the mammalian complex in its native
membrane (Jones et al., 2016) and are similar to the highest
activities reported for isolated bacterial complex I (Sazanov
et al., 2003; Verkhovsky et al., 2012), so they confirm both
the integrity of the purified complex and the reversibility of
the deactivation procedure.
Imaging, Classification, and Structure Modeling for the
Deactive Enzyme
Quantifoil holey carbon grids were used previously to image
mammalian complex I (Fiedorczuk et al., 2016; Vinothkumar
et al., 2014; Zhu et al., 2016). However, in common with many
other proteins, the complex binds to the oxidatively modified
carbon, depleting it from the vitreous ice in the holes and leading
to poorly distributed particles and low particle numbers for imag-
ing. Self-assembled monolayers with controlled surface proper-
ties and lower protein affinities have been developed to mitigate
this problem (Meyerson et al., 2014), and here we usedUltrAuFoil
Figure 1. Spectrophotometric Catalytic Activity Assay of NADH:
Decylubiquinone Oxidoreduction by Isolated Deactive Complex I
Assay traces comparing enzyme that had been treated by 4 mM NEM (red)
with enzyme that had not been treated (green). Without the NEM treatment the
deactive protein gradually reactivates, reaching its maximal rate after 150 s.
The NEM treatment prevents reactivation and the background rate is only from
the small proportion of active enzyme present. Experiments were carried out
using 200 mMNADH, 200 mM decylubiquinone, and 0.5 mg mL1 complex I, as
described in the STAR Methods.
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gold grids (Russo and Passmore, 2014) derivatized with a poly-
ethylene glycol (PEG) linked by an alkanethiol; the 11-carbon
alkanethiol forms a robust bond to the gold surface and exposes
the biocompatible PEG-6 group to the protein solution (Meyer-
son et al., 2014). In a side-by-side comparison with the previ-
ously used Quantifoil grids, we found four times more particles
could be imaged per hole using the PEGylated gold grids (see
Figure 2), plus the particle distribution was improved and less
aggregation was observed (see Figure S1). Subsequently, it
also became clear that the particles adopt a broader set of orien-
tations on the PEGylated gold than the Quantifoil grids (see Fig-
ure S2). In addition to altered grid-protein interactions, varying
ice thicknesses may also contribute to the improved distribution,
and the amorphous carbon Quantifoil grids may absorb deter-
gent from the solution, altering the properties of the air-water
interface during grid preparation and increasing the chance of
aggregation.
The deactive complex on the PEGylated gold grids was
imaged at 300 kV using a Titan Krios electron microscope and
a Falcon-II direct electron detector (McMullan et al., 2014). In
total, ca. 148,000 particles were picked manually, and ca.
125,000 particles were retained following two-dimensional (2D)
and coarsely sampled three-dimensional (3D) classification.
Using the RELION software suite (Scheres, 2012, 2014), the
dataset was first refined to produce a 4.7 A˚ resolution density
map. Following per-particle frame alignment and B-factor
weighting (Scheres, 2014), the final resolution was 4.13 A˚
(defined where the Fourier shell correlation [FSC] = 0.143)
(Rosenthal and Henderson, 2003) (see Figure S3).
The ca. 125,000 particles with improved signal to noise
following frame alignment and B-factor weighting were then sub-
jected to 3D classification with incrementally increasing angular
sampling (up to 0.9) (Scheres, 2016). The results are shown in
Figure 3. Classification into three classes resulted in a dominant
class containing 87.5% of the particles, a minor class containing
9.7%, and a negligible third class containing 2.7%. When the
classification was repeated but with six classes, a similar pattern
emerged: two major classes contained 87.0% and 7.9% of the
particles (matching their equivalent classes from before) and
the remaining four classes were all negligible (1.3%, 1.6%,
0.6%, and 1.5%). The two largest classes from the first evalua-
tion were refined individually, leading to cryo-EM density maps
of formally 4.13 and 7.50 A˚ resolution. The map for the dominant
class at 4.13 A˚ resolution, which we assign to the structure of de-
active complex I, was taken forward tomodel building (see Table
S1). Although the formal resolution of 4.13 A˚ is only marginally
higher than reported previously for the bovine complex (4.27 A˚
for class 1 and 4.35 A˚ for class 2) (Zhu et al., 2016), several re-
gions of the map displayed substantially improved features
(see Figure S4 for example densities). Consequently, by incorpo-
rating information from the recently published ovine model and
map (Fiedorczuk et al., 2016), we were able to assign sequence
to the large domain of the 75 kDa (NDUFS1) core subunit (see
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Figure 2. Comparison of the Number of Particles Observed Per
Micrograph Using PEGylated Gold and Quantifoil Holey Car-
bon Grids
The samples of deactive complex I used were at concentrations of 4.4 mg
mL1 (PEGylated gold UltrAuFoil 0.6/1) and 4.2mgmL1 (Quantifoil 0.6/1). The
PEGylated gold grids were prepared using a Vitrobot (see STARMethods) and
the Quantifoil grids by manual blotting as described previously (Vinothkumar
et al., 2014; Zhu et al., 2016). The data are from two automated data collection
sessions on a Titan Krios microscope (see STAR Methods for imaging pa-
rameters) and the particles were picked manually in each case.
2D classification
3D classification (7.5° sampling)
3D autorefinement & particle polishing
3D classification (up to 0.9° sampling)
 
2.7 %
3k particles
Minor class
9.7 %
12k particles
Dominant class
87.5%
110k particles
125k particles
139k particles
Manual particle picking
148k particles
~28 Å7.5 Å4.1 Å
3D autorefinement
Figure 3. Classification andRefinement of theCryo-EMDensityMap
for Deactive Complex I
The RELION pipeline (Scheres, 2012) was used to process data from the de-
active preparation. Following manual particle picking and 2D and 3D classifi-
cation to discard bad particles, 3D refinement and particle polishing were
performed. Subsequently, the particles were classified using an angular
sampling up to 0.9 and with the resolution limited to 8 A˚ (see STARMethods).
All three classes provided were populated. The dominant class refined to
4.1 A˚, and a minor class to 7.5 A˚. The remaining class is negligible as it con-
tained so few particles.
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Table S2), to provide a fully assigned model for all 14 core sub-
units (note that we refer to the subunits using both their bovine
and human nomenclatures as summarized in Tables S2 and
S3). In addition, we were able to fully assign the sequences of
the 42 kDa (NDUFA10), 18 kDa (NDUFS4), 13 kDa (NDUFS6),
10 kDa (NDUFV3), PGIV (NDUFA8), SGDH (NDUFB5), and B22
(NDUFB9) supernumerary subunits, and to increase the level of
sequence assignment in the B16.6 (NDUFA13), B15 (NDUFB4),
B14.5a (NDUFA7), and B14.5b (NDUFC2) subunits (see
Table S3). Overall, our model contains 7,811 residues, of
which 7,004 (90%) are assigned, increased from 71% in the
previous class 1 model for the bovine enzyme (Zhu et al., 2016).
Structural Rearrangements of the Ubiquinone-Binding
Site Region in Deactive Complex I
The cryo-EM density map for the biochemically defined deactive
enzyme contains specific regions of localized disorder around
the ubiquinone-binding site. Continuous densities for the loop
between TMHs 5 and 6 in the ND1 subunit, the loop between
TMHs 1 and 2 in the ND3 subunit (containing Cys39), the short
loop between the b1 and b2 strands in the 49 kDa (NDUFS2)
subunit (containing His59, one of the ligands to the bound
ubiquinone head group), and several nearby loops in the
39 kDa (NDUFA9) subunit are not observed in the map (see
Figure 4). The same regions are absent from the previously
described class 1 density map but were clearly observed in the
class 2 map, despite its resolution being lower (Zhu et al.,
2016) (see Figure S5 for example densities). Therefore, the loss
of ordered structures around the ubiquinone-binding site is char-
acteristic of the deactive enzyme. The ubiquinone access chan-
nel was tentatively identified in the class 2 map, leading from an
entrance in ND1 to the binding site for the ubiquinone head
group, at the top of a cleft between the 49 kDa and PSST sub-
units (Zhu et al., 2016). A similar channel was identified in the
crystal structure of complex I from Thermus thermophilus, which
does not exhibit a clear active-deactive transition and can thus
be assumed to be in an active state (Baradaran et al., 2013).
The channel cannot be identified in the structure of the deactive
enzyme because key structural elements that form it are
disordered and missing from the model. We conclude that the
ubiquinone-binding channel has lost its structural integrity in
the deactive complex.
Assignment of Classes 1, 2, and 3
The preparation of bovine complex I imaged by Zhu et al. (2016)
comprised a mixture of deactive and active enzymes and three
structural classes (classes 1, 2, and 3) were distinguished. Disor-
dered regions observed here in the biochemically defined
deactive complex were disordered in class 1 but not in class 2.
The 5.6 A˚ resolution of the class 3 density map is too low for a
similar comparison, but class 3 is clearly distinguished by addi-
tional disorder (not present in classes 1 and 2) in the C-terminal
section of ND5 (including the transverse helix and TMH16) and
part of the adjacent subunit B14.7 (NDUFA11), consistent with
it being partially dissociated and irreversibly inactivated (Zhu
et al., 2016). ND5 and B14.7 (NDUFA11) are both represented
by clear density in the deactive enzyme (see Figure S5), support-
ing assignment of class 1 to the deactive state. Two global com-
parisons were further used to compare the deactive enzymewith
classes 1, 2, and 3. Previously, small shifts and rotations in
different enzyme domains were observed between the classes.
For example, with the structures superimposed on ND1 (in the
‘‘heel’’ of the enzyme), the hydrophilic domain rotates by 3.4
and the membrane domain by 3.9 between classes 1 and 2,
and the distal portion of the membrane domain a further 3.1 be-
tween classes 1 and 3 (Zhu et al., 2016). To capture these global
rearrangements, map/model correlations were calculated to
evaluate how well the Ca chains from classes 1, 2, and 3 fit the
deactive complex I density map (see Table 1). In addition, root-
mean-square deviation (RMSD) values were obtained for
different sections of the membrane domain, following alignment
of the hydrophilic domains of the deactive model and classes 1,
2, and 3 (see Table 1). Both approaches support the assignment
of class 1 to the deactive enzyme. Furthermore, the minor (9.7%)
class in the deactive preparation matches the class 3 structure
reported previously (Zhu et al., 2016); it displays disorder in
both theC-terminal section ofND5and subunit B14.7 (NDUFA11)
Figure 4. The Structure of Deactive Complex I Is Characterized by
Localized Unfolding
(A and B) Structure of intact complex I with an arrow showing the view taken of
the ubiquinone-binding region (A). The distal section of the membrane domain
(shown in wheat) is not included in (B) and (C). (B) View of the ubiquinone-
binding region with the subunits involved shown in color as indicated.
(C) Close-up of the ubiquinone-binding region, from the same perspective as in
(B) with the ubiquinone-binding channel predicted for the class 2 structure
(Zhu et al., 2016) shown in blue. The colors are lighter versions of those used in
(B). The areas that become disordered in the deactive state (the loops between
TMHs 1 and 2 in ND3, TMHs 5 and 6 in ND1, b1 and b2 in the 49 kDa [NDUFS2]
subunit, and parts of the 39 kDa [NDUFS9] subunit) are shown in red. His59 is
one of the residues likely to interact with the bound ubiquinone head group;
Cys39 is the marker residue for the deactive state. The figure was created by
combining 5LC5.PDB for the active enzyme (Zhu et al., 2016) with information
about the deactive state described here.
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and has the highest map/model correlation with class 3 (see
Table 1). This match is consistent with a small proportion of
partially denatured enzyme in grids of the deactive complex.
With class 1 confirmed as the deactive state, increased struc-
turing of the ubiquinone-binding site in class 2 and the similarities
between the ubiquinone-binding channels detected in class 2
and in complex I from T. thermophilus (Baradaran et al., 2013;
Zhu et al., 2016) argue strongly that class 2 represents the active
enzyme, the state that is ready for substrate binding.
Comparison with Structures from Other Mammalian
Species
Using similar criteria, the classes represented by published cryo-
EM structures from other mammalian species were evaluated.
For the isolated ovine complex in brij-35 at 3.9 A˚ resolution (Fie-
dorczuk et al., 2016), no continuous densities are present for the
loops that are disordered in the bovine deactive state (despite
the overall resolution being higher than that of the active class 2
structure) or for the C-terminal section of ND5 or subunit
B14.7 (NDUFA11) that are disordered in bovine class 3 (see Fig-
ure S5). RMSD calculations of the protein models between
different species are confounded by variations in sequence
numbering, but map/structure correlations (see Table 1) support
the ovine structure matching the bovine class 3 (inactive) state.
Previously, the ovine structure was assigned to the deactive
state (Fiedorczuk et al., 2016), and a second, lower-resolution
class (not available for analysis) to the active state. However,
the specific activity of the preparation (in the detergent brij-35
to increase particle density on the grids) was only 3.5 mmol
NADH min1 mg1 (Fiedorczuk et al., 2016; Letts et al., 2016b),
equivalent to 16% of the activity reported here and consistent
with a large proportion of inactive enzyme. For complex I in the
ovine supercomplex in digitonin (Letts et al., 2016a), the resolu-
tion is too low to observe specific loops, but map/structure cor-
relations suggest it is predominantly in the class 1 (deactive)
state. For complex I in the porcine supercomplex, also in digi-
tonin (Gu et al., 2016;Wu et al., 2016), map/structure correlations
indicate it is in the class 2 (active) state and this is supported by
clear density for the ND3, ND1, 49 kDa (NDUFS2), and 39 kDa
(NDUFA9) subunit loops (see Figure S5). A recent structure of
the bovine supercomplex is too low resolution to allow either
specific structural elements or map/model correlations to distin-
guish the class (Sousa et al., 2016). Finally, although supercom-
plex formation is independent of the deactive/active status of
complex I (Ciano et al., 2013), incorporating complex I into a
supercomplex may both stabilize the unstable region around
the C-terminus of ND5 and subunit B14.7 (NDUFA11) that is
buttressed against complex III and influence the conformation
of the membrane arm as it curves around it.
DISCUSSION
The complex I preparations used here have specific activities at
least 2-fold higher than those used in our previous cryo-EM
studies of bovine complex I (Sharpley et al., 2006; Zhu et al.,
2016). However, based on particle classification (Scheres,
2016), the fraction of class 3 inactive particles has only
decreased from 20% to 10%, questioning whether the class
populations observed on the grids accurately reflect the class
populations in solution. Many proteins denature at the large
air-water interface present during cryo-EM grid formation (Pass-
more and Russo, 2016), so class 1 and 2 molecules may
augment the class 3 population or become more completely de-
natured and (having lost their distinctive L shape) invisible to the
analysis. Our observation cautions against relying on the classi-
fication of mixed populations of subtly different particles when
assigning biochemically known states, and suggests that
higher-resolution structures of mammalian complex I set in cata-
lytically relevant states will require homogeneous preparations
combined with solution conditions that maintain their stability
during grid preparation. Here, the deactive complex was pre-
pared in a homogeneous state that is reflected in the class
Table 1. Comparison of the Structure of the Deactive Enzyme
with the Previously Determined Class 1, 2, and 3 Structures
Map/Model Correlation
Class 1
PDB: 5LDW
Class 2
PDB: 5LC5
Class 3
PDB: 5LDX
Dominant class
(this study)
0.1988* 0.1496 0.1772
Minor class (this study) 0.1097 0.1026 0.1218*
Ovine-brij (EMD-4084) 0.1615 0.1388 0.1775*
Ovine supercomplex
(EMD-8130)
0.1376* 0.1206 0.1285
Porcine supercomplex
(EMD-9539)
0.0718 0.0745* 0.0635
RMSD values (dominant class)
Hydrophilic domain 1.75 1.77 1.77
Hydrophobic domain: all 1.33* 5.88 3.16
Hydrophobic domain:
proximal
0.90* 3.55 1.03
Hydrophobic domain:
distal
1.63* 7.42 4.28
RMSD values (minor class)
Hydrophilic domain 1.78 1.80 1.77
Hydrophobic domain: all 5.33 7.37 1.94*
Hydrophobic domain:
proximal
1.70 3.89 0.94*
Hydrophobic domain:
distal
7.23 9.53 2.54*
Map/model correlations were fromUCSFChimera and obtained by fitting
the Ca chains for classes 1, 2, and 3 into the maps from the deactive
preparation, where larger values indicate a better fit. RMSD values are
for the Ca coordinates for the deactive complex (dominant class)
compared with classes 1, 2, and 3, where smaller values indicate a better
fit. Following superposition (using the Pymol ‘‘super’’ routine) of all the
models on the Ca structures of the core subunits in their hydrophilic do-
mains (chains B, C, D, E, F, G, and I), RMSD values were calculated for
sets of core subunits in the membrane domain. The core hydrophobic
domain consists of chains A, H, J, K, L, M, and N, the proximal domain
of chains A, H, J, K, and N, and the distal domain of chains L and M.
The N terminus (residues 1–39) of chain D was excluded. A model for
theminor class was generated by performing real-space rigid-body fitting
of each of the dominant class model chains to the minor class density in
Phenix (Adams et al., 2010). Values that match best to the different clas-
ses are marked with asterisks.
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populations on the cryo-EM grids, giving confidence in its struc-
tural assignment.
The structure of bovine complex I set in the deactive state sup-
ports the unfolded Q-site model (Dro¨se et al., 2016; Zhu et al.,
2016) for the deactive transition of the mammalian enzyme.
The competing truncated Q-site model was originally proposed
using structural data from Y. lipolytica complex I (Zickermann
et al., 2015). However, the structure described has an inhibitor
bound adjacent to the loop that truncates the channel, which
may stabilize it in an alternative conformation. Furthermore, the
transition is less pronounced in Y. lipolytica than in mammalian
species: interconversions between the active and deactive
states are faster and associated with much lower activation en-
ergies (Grivennikova et al., 2003; Maklashina et al., 2003). Thus,
the structural changes of the deactive transition in the yeast
enzyme may be less extensive than in the mammalian enzyme.
The ubiquinone-binding channel was observed to be similarly
truncated in the structure of ovine complex (Fiedorczuk et al.,
2016). However, the ovine complex has very low specific activity,
correlates structurally to the inactive class 3 bovine complex,
and the density for the loop in question is not well resolved
(see Figure S5). The ovine structure (and bovine class 3) probably
represent inactive states that cannot be reactivated.
The flexibility of the structural elements that become disor-
dered in the deactive state (see Figure 4) is further underlined
by the different conformations they adopt in structural models
determined for different species, from the mammalian (Fiedorc-
zuk et al., 2016; Wu et al., 2016), yeast (Zickermann et al., 2015),
and bacterial (Baradaran et al., 2013) enzymes, consistent with
them having important functional roles. The ND3 loop appears
to be a ‘‘tether’’ from the membrane domain, on the front of
the hydrophilic domain and ubiquinone-binding channel; the
ND1 loop forms the base of the ubiquinone-binding channel at
the hydrophobic-hydrophilic domain interface; the b1-b2 loop
in the 49 kDa (NDUFS2) subunit carries a histidine that ligates
the ubiquinone head group. All these loops are crucial for both
the integrity of the ubiquinone-binding channel and the structure
of the domain interface, which they appear to maintain in an acti-
vated state (analogous to a compressed spring) in the active
enzyme. Upon deactivation, the interface relaxes, with conse-
quent changes to the relative arrangement of the two domains.
Thus, we propose that the deactive state is a reversibly formed
off-pathway state and not, as suggested previously (Zickermann
et al., 2015), a catalytic intermediate. The disordered elements
are confined by adjacent secondary structures, and the disor-
dered region in general may be stabilized by the supernumerary
39 kDa (NDUFA9) subunit on the outside of the core complex. In
the inactive class 3 structure, loss of structural integrity in the
ND5 transverse helix appears to allow further relaxation within
the membrane domain and the proximal section of the mem-
brane domain to begin to break from the rest of the complex
(Zhu et al., 2016). Thus, like the loop in ND3, the transverse helix
can also be considered to be a tether that maintains the enzyme
in an active conformation.
Structural knowledge of the deactive state of mammalian
complex I now provides a basis for understanding many of its
biochemical features. (1) Cys39 in subunit ND3, which is both
used as a marker for the deactive state (Galkin et al., 2008)
and targeted in strategies to minimize ischemia-reperfusion
injury, by using cysteine-modifying agents to slow reactivation
or to protect the cysteine against irreversible oxidation (Chou-
chani et al., 2013; Galkin et al., 2009; Gorenkova et al., 2013),
is on the (disordered) loop between TMHs 1 and 2. It is occluded
in the active state andmust become solvent accessible in the de-
active state. (2) Structural disorder in the ND3, ND1, and 39 kDa
(NDUFA9) subunits in the deactive state explains the results of
cross-linking studies that identified these subunits as changing
conformation in the deactive state (Babot et al., 2014b; Ciano
et al., 2013). (3) Relaxation of the activated interface between
the hydrophobic and hydrophilic domains upon formation of
the deactive state is consistent with the functional connection
between them breaking down upon deactivation. Thus, the pro-
ton transfer subunits in the hydrophobic domain are freed from
control by the redox reaction in the hydrophilic domain and
may function independently of it, resulting in the Na+/H+ anti-
porter activity that has been observed specifically in the deactive
state (Roberts and Hirst, 2012). (4) The unfolded Q-site model for
the deactive state explains why slow reactivation of the deactive
enzyme only occurs in the presence of NADH and ubiquinone
(Kotlyar and Vinogradov, 1990). We propose that ubiquinone
acts as a template to restructure the site in the NADH-reduced
enzyme in an induced-fit mechanism of substrate binding (Kosh-
land, 1994). It is possible that electron transfer from N2 to the
bound ubiquinone is also required for complete activation. The
requirement for ubiquinone to bind to the reduced enzyme ex-
plains why neither reverse electron transfer (ubiquinol:NAD+ ox-
idoreduction) nor its associated reactive species production are
catalyzed by the deactive enzyme upon the reperfusion of
ischemic tissue (Chouchani et al., 2013; Kotlyar and Vinogradov,
1990). (5) The ubiquinone-site inhibitor rotenone has also been
reported to return the deactive enzyme to its active state (Griven-
nikova et al., 1997), consistent with its inhibition of the Na+/H+
antiporter activity of the deactive state (Roberts and Hirst,
2012). (6) The flexibility and ability of the structural elements
that constitute the active site to reorganize around substrates
and inhibitors may explain why so many diverse compounds
are known to inhibit ubiquinone reduction by complex I
(Miyoshi, 1998;Murai andMiyoshi, 2016). Similarly, the instability
of the ubiquinone-binding site region, which propagates
structural flexibility through the enzyme, may explain why the
mammalian enzyme has proved so difficult to purify in a highly
catalytically active state and (so far) to crystallize for structure
determination.
Finally, disordered protein domains are increasingly recog-
nized as central to many diverse molecular processes and as
particularly important in regulatory mechanisms (van der Lee
et al., 2014). The deactive state of complex I is already being
explored as a regulatory mechanism relevant to minimizing
ischemia-reperfusion injury (Chouchani et al., 2013), and the
structure of the deactive state now highlights additional possibil-
ities. Inherent conformational flexibility in the loop of ND3 that
carries the highly conserved Cys39 may transiently expose it to
post-translational modifications that regulate complex I activity
in response to cellular redox status. Alternatively, several disor-
dered regions accumulated into one area may allow an effector
protein to interact, to trap the enzyme in the deactive state, or
promote its formation. Studies of the deactive-active status of
complex I under physiologically relevant conditions and of the
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deactive state formed in vivowill be required to investigate these
suggestions in the future.
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KEY RESOURCES TABLE
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by Judy Hirst (jh@mrc-mbu.
cam.ac.uk).
EXPERIMENTAL MODEL DETAILS
Bovine hearts were obtained from Dawn Cardington Abattoir, Bedford, U.K. and were of the common cattle breeds found in the
United Kingdom. The cattle were of mixed gender and typically slaughtered at 18 – 22 months old.
METHOD DETAILS
Preparation of Complex I Samples
Bovine mitochondria andmitochondrial membranes were prepared as described previously (Blaza et al., 2014). Complex I was set in
the deactive state by incubating the membranes (resuspended to 12 mg protein mL-1 in 20 mM Tris-Cl pH 7.55, 1 mM EDTA, 10%
glycerol, 0.0075% PMSF) at 37C for 15 min. Then, the membranes were diluted to 5 mg mL-1 in the same buffer but ice cold, and
cooled on ice for 10 min. All subsequent steps were performed at 4C, using a protocol developed from that of Jones et al.
(Jones et al., 2016). Briefly, n-dodecyl b-D-maltoside (DDM, Glycon Biochemicals GmbH) was added dropwise to 1%, the
suspension stirred for 20 min., clarified by centrifugation (47,0003 g for 12 min.) and loaded onto a Q-sepharose column pre-equil-
ibrated in buffer A (20 mM Tris-Cl pH 7.55, 2 mM EDTA, 10% ethylene glycol, 0.2% DDM, 0.02% asolectin (Avanti Polar Lipids) and
0.02% CHAPS (Santa Cruz Biotechnology)). Cytochrome c oxidase and other unwanted proteins were eluted in 27.5% buffer B
(buffer A with 1 M NaCl added), until the absorbance at 420 nm
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
DDM Glycon D97002
Cymal-7 Anatrace C327
CHAPS Santa Cruz Biotechnology sc-29088
NADH Sigma Aldrich N8129 (Na salt)
asolectin Avanti Polar Lipids 541602P
decylubiquinone Santa Cruz Biotechnology sc-358659
SPT-11P6 (PEGylation reagent) SensoPath Technologies SPT-11P6
Deposited Data
Density map of the major class This paper EMD-3731
Density map of the minor class This paper EMD-3733
The built model of the major class This paper PDB-5O31
Experimental Models: Organisms/Strains
Bos taurus Dawn Cardington Abattoir, Bedford, U.K N/A
Software and Algorithms
Relion-1.4 Scheres, 2012 http://www2.mrc-lmb.cam.ac.uk/relion
CTFFIND4 Rohou and Grigorieff, 2015 http://grigoriefflab.janelia.org/ctffind4
ResMap Kucukelbir et al., 2014 http://resmap.sourceforge.net/
PHENIX Adams et al., 2010 https://www.phenix-online.org/
REFMAC5 Murshudov et al., 2011; Murshudov, 2016 http://www.ccp4.ac.uk
Coot Emsley et al., 2010 http://www.ccp4.ac.uk
Other
UltrAuFoil gold grids (0.6/1) Quantifoil No product code
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reached 0.025, then complex I was eluted in 36% buffer B. The complex I-containing fractions were pooled and concentrated to
1 mL, then eluted from a 10/300 superose-6 increase column (GE Healthcare Life Sciences) at 0.5 mL min-1 in 20 mM Tris-Cl
pH 7.55, 150 mM NaCl, and 0.04% Cymal-7 (Anatrace). The manually collected peak fraction with concentration 4 mg mL-1 was
used immediately for grid preparation.
Catalytic Activity Assays and Determination of the Deactive/Active Enzyme Ratio
NADH:decylubiquinone oxidoreductase activities of isolated complex I samples were determined at 32C using 0.5 mg
complex I mL-1 with 200 mM NADH and 200 mM decylubiquinone in 20 mM Tris-Cl pH 7.5, 0.15% asolectin and 0.15% CHAPS.
The reaction was initiated by addition of NADH and the rate determined following activation of the deactive enzyme, when (typically
2min. after initiation) the kinetic trace (recorded at 340 - 380 nm, 3NADH = 4.81mM
-1 cm-1) becomes linear. To determine the deactive/
active enzyme status an aliquot of the complex I stock solution (at 4 mg mL-1) was divided into two and 4 mM NEM added to one
half. The samples were incubated at 4C for at least 5 minutes (longer incubations did not increase the level of inhibition) before their
addition to the assay mixture to measure their relative maximum rates of catalysis. In the absence of NEM catalysis is from both the
active and deactive enzymes, in the presence of NEM only from the active enzyme.
Cryo-EM Grid Preparation
For the data collection presented, UltrAuFoil gold grids (0.6/1, Quantifoil Micro Tools GmbH) (Russo and Passmore, 2014) were glow
discharged at 20 mA for 60 s then imported to an anaerobic glovebox and placed in ethanol containing 5 mM 11-mercaptoundecyl
hexaethyleneglycol (SPT-0011P6, SensoPath Technologies) for at least 24 hours before grid preparation (Meyerson et al., 2014).
Then, just prior to use, the grids were washed three times in ethanol and left to air-dry. Grids were prepared using an FEI
Vitrobot IV. 2.5 mL of protein solution were applied to the grid at 4C in 100% relative humidity, and blotted for 8 – 12 s at force
setting -10, before being plunged into liquid ethane. For comparative experiments, UltrAuFoil 1.2/1.3 gold grids and Quantifoil
0.6/1 grids were prepared similarly, but using 8 and 2 s blotting times, respectively, or prepared bymanual blotting as described pre-
viously (Vinothkumar et al., 2014).
Electron Microscopy
Grids were imaged in a 300 keV Titan Krios microscope fitted with a Falcon-II direct electron detector and EPU software at the Elec-
tron Bio-Imaging Centre at The Diamond Light Source. The nominal magnification was set to 59,0003 but, by comparing the final
4.13 A˚ structure to the previously published class 1 structure, the pixel size was calibrated to 1.38 A˚ and the magnification to
101,4493. A C2 and objective aperture of 100 mm were used and each image was exposed for 2.5 s with a total dose of 80 elec-
trons/A˚2. We collected the first 12 frames (700 ms) to capture the rapid early movement of the sample when the electron beams first
interacts with the grid (Brilot et al., 2012) and after that every four frames were binned together. The defocus range was 1.3-3.1 mm in
0.3 mm increments; defocus was measured in the autofocus routine every 10 mm.
Image Processing
Whole-frame alignment was performing using Unblur (Grant andGrigorieff, 2015) before CTF estimation using CTFFIND4 (Rohou and
Grigorieff, 2015). All resolution estimates are based on the FSC = 0.143 criterion, and the final resolution estimates were made after
the application of a binary mask and phase-randomization to check the effects of the mask. RELION-1.4 was used for data process-
ing (Scheres, 2012).
A total of 148,488 particles were picked manually. Following 2D and 3D classification to remove ‘bad’ particles, 125,006 particles
were used for refinement to a resolution of 4.7 A˚. Per-particle frame alignment to correct for movement and B-factor weighting
(Scheres, 2014) were then performed and the resolution, following a second refinement, improved to 4.13 A˚ with an angular accuracy
of 0.87. The resulting ‘shiny’ particles were subjected to 3D classification with three classes, with the angular sampling gradually
increased up to 0.9 and the resolution limited to 8 A˚ to reduce over-fitting; local searches were implemented from 3.75 onwards.
The populations within the classes remained stable for at least 50 further iterations after the different classes had emerged. The
three classes (see Figure 3) were refined individually. The dominant class had a resolution of 4.13 A˚ and was sharpened with a B-fac-
tor of -110 A˚2 before model building.
Model Building
We extended our previous class 1 model (Zhu et al., 2016) to assign more residues, using the improved densities visible in the new
map, and the better densities for the hydrophilic domain in the ovine map (Fiedorczuk et al., 2016). Typically, the approximate
numbering of the unknown residues (Zhu et al., 2016) was found to be quite accurate, with bulky residues being found already placed
in bulky pockets of density. In regions in which the numbering of the residues is still uncertain a poly-Ala chain was used to provide
approximate numbers. The resulting model was further manually fitted in Coot (Emsley et al., 2010) and refined using REFMAC5
(Murshudov, 2016; Murshudov et al., 2011). Sidechains were included where appropriate. Note that we number the residues in
the subunits starting from the first residue of the mature protein (Hirst et al., 2003). Note also that the density assigned to the
10 kDa (NDUFV3) subunit in both the bovine and ovine structures (Fiedorczuk et al., 2016; Zhu et al., 2016) was assigned to the
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N-terminal mitochondrial targeting sequence of the 24 kDa subunit (NDUFV2) in the porcine structure (Wu et al., 2016) but it is cleaved
from the mature protein and not present in the isolated enzyme (Hirst et al., 2003).
DATA AVAILABILITY
The electron microscopy maps and model have been deposited in the Electron Microscopy Databank, accession codes
EMD-3733 for the minor class and EMD-3731 for the major class, and in the Protein Data Bank, accession code PDB: 5O31 for
the major class.
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